Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 5013132, 11 pages
http://dx.doi.org/10.1155/2016/5013132
Research Article

Prevalence and Characteristics of CAM Use among People Living with HIV and AIDS in Lebanon: Implications for Patient Care

1Department of Nutrition and Food Sciences, Faculty of Agriculture and Food Sciences, American University of Beirut, Riad El-Solh, Beirut 1107 2020, Lebanon
2Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14, Dubai Healthcare City, P.O. Box 505055, Dubai, UAE
3Department of Health Management and Policy, Faculty of Health Sciences, American University of Beirut, Riad El-Solh, Beirut 1107 2020, Lebanon

Received 2 August 2016; Accepted 7 November 2016

Academic Editor: Oliver Micke

Copyright © 2016 Joana Abou-Rizk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Fesharakinia and M. Abedini, “Prevalence of using complementary and alternative medicine in children and its related factors in east Iran,” Iranian Journal of Pediatrics, vol. 24, no. 1, pp. 105–108, 2014. View at Google Scholar · View at Scopus
  2. N.C.f.C.a.I.H. (NCCIH), “Complementary, Alternative, or Integrative Health: What's In a Name?” https://nccih.nih.gov/health/integrative-health.
  3. WHO, “Traditional Medicine: Definitions,” 2016, http://www.who.int/medicines/areas/traditional/definitions/en/.
  4. E. Chitindingu, G. George, and J. Gow, “A review of the integration of traditional, complementary and alternative medicine into the curriculum of South African medical schools,” BMC Medical Education, vol. 14, no. 1, article no. 40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. P. M. Barnes, E. Powell-Griner, K. McFann, and R. L. Nahin, “Complementary and alternative medicine use among adults: United States, 2002,” Advance Data, no. 343, pp. 1–19, 2004. View at Google Scholar
  6. S. L. Thomas, K. Lam, L. Piterman, A. Mijch, and P. A. Komesaroff, “Complementary medicine use among people living with HIV/AIDS in Victoria, Australia: practices, attitudes and perceptions,” International Journal of STD and AIDS, vol. 18, no. 7, pp. 453–457, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. Littlewood and P. A. Vanable, “A global perspective on complementary and alternative medicine use among people living with HIV/AIDS in the era of antiretroviral treatment,” Current HIV/AIDS Reports, vol. 8, no. 4, pp. 257–268, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Hoogbruin, “Complementary and alternative therapy (CAT) use and highly active antiretroviral therapy (HAART): current evidence in the literature, 2000–2009,” Journal of Clinical Nursing, vol. 20, no. 7-8, pp. 925–939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Lorenc and N. Robinson, “A review of the use of complementary and alternative medicine and HIV: issues for patient care,” AIDS Patient Care and STDs, vol. 27, no. 9, pp. 503–510, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. O. I. Ekwunife, C. Oreh, and C. M. Ubaka, “Concurrent use of complementary and alternative medicine with antiretroviral therapy reduces adherence to HIV medications,” International Journal of Pharmacy Practice, vol. 20, no. 5, pp. 340–343, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Dhalla, K. J. Chan, J. S. G. Montaner, and R. S. Hogg, “Complementary and alternative medicine use in British Columbia—a survey of HIV positive people on antiretroviral therapy,” Complementary Therapies in Clinical Practice, vol. 12, no. 4, pp. 242–248, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Peltzer, N. F.-D. Preez, S. Ramlagan, and H. Fomundam, “Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa,” BMC Public Health, vol. 8, article 255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. E. Bormann, C. R. Uphold, and C. Maynard, “Predictors of complementary/alternative medicine use and intensity of use among men with HIV infection from two geographic areas in the United States,” Journal of the Association of Nurses in AIDS Care, vol. 20, no. 6, pp. 468–480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Nlooto, “Views and experiences of healthcare professionals towards the use of African traditional, complementary and alternative medicines among patients with HIV infection: the case of eThekwini health district, South Africa,” BMC Complementary and Alternative Medicine, vol. 15, article 170, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. M. D. Furler, T. R. Einarson, S. Walmsley, M. Millson, and R. Bendayan, “Use of complementary and alternative medicine by HIV-infected outpatients in Ontario, Canada,” AIDS Patient Care and STDs, vol. 17, no. 4, pp. 155–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. J. P. Liu, E. Manheimer, and M. Yang, “Herbal medicines for treating HIV infection and AIDS,” Cochrane Database Of Systematic Reviews (Online), no. 3, p. CD003937, 2005. View at Google Scholar · View at Scopus
  17. M. O. Johnson, S. E. Dilworth, J. M. Taylor, and T. B. Neilands, “Improving coping skills for self-management of treatment side effects can reduce antiretroviral medication nonadherence among people living with HIV,” Annals of Behavioral Medicine, vol. 41, no. 1, pp. 83–91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Duggan, W. S. Peterson, M. Schutz, S. Khuder, and J. Charkraborty, “Use of complementary and alternative therapies in HIV-infected patients,” AIDS Patient Care and STDs, vol. 15, no. 3, pp. 159–167, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. T. J. Birk, A. McGrady, R. D. MacArthur, and S. Khuder, “The effects of massage therapy alone and in combination with other complementary therapies on immune system measures and quality of life in human immunodeficiency virus,” Journal of Alternative and Complementary Medicine, vol. 6, no. 5, pp. 405–414, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Power, C. Gore-Felton, M. Vosvick, D. M. Israelski, and D. Spiegel, “HIV: effectiveness of complementary and alternative medicine,” Primary Care—Clinics in Office Practice, vol. 29, no. 2, pp. 361–378, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Owen-Smith, L. DePadilla, and R. DiClemente, “The assessment of complementary and alternative medicine use among individuals with HIV: a systematic review and recommendations for future research,” Journal of Alternative and Complementary Medicine, vol. 17, no. 9, pp. 789–796, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Palmer, “Use of complementary therapies to treat patients with HIV/AIDS,” Nursing standard (Royal College of Nursing (Great Britain): 1987), vol. 22, no. 50, pp. 35–41, 2008. View at Google Scholar · View at Scopus
  23. C. Liu, Y. Yang, S. J. Gange et al., “Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women,” AIDS Patient Care and STDs, vol. 23, no. 11, pp. 965–971, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. F. A. Munoz, A. E. Servin, J. Kozo, M. Lam, and M. L. Zuniga, “A binational comparison of HIV provider attitudes towards the use of complementary and alternative medicine among HIV-positive Latino patients receiving care in the US-Mexico border region,” AIDS Care, vol. 25, no. 8, pp. 990–997, 2013. View at Google Scholar
  25. R. A. Elion and C. Cohen, “Complementary medicine and HIV infection,” Primary Care: Clinics in Office Practice, vol. 24, no. 4, pp. 905–919, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. A. C. Irish, “Maintaining health in persons with HIV infection,” Seminars in Oncology Nursing, vol. 5, no. 4, pp. 302–307, 1989. View at Publisher · View at Google Scholar · View at Scopus
  27. S. S. Hasan, C. K. See, C. L. K. Choong, S. I. Ahmed, K. Ahmadi, and M. Anwar, “Reasons, perceived efficacy, and factors associated with complementary and alternative medicine use among Malaysian patients with HIV/AIDS,” Journal of Alternative and Complementary Medicine, vol. 16, no. 11, pp. 1171–1176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. N. P. Mbutho, N. Gqaleni, and C. M. Korporaal, “Traditional complementary and alternative medicine: knowledge, attitudes and practices of health care workers in HIV and AIDS clinics in Durban hospitals,” African Journal of Traditional, Complementary, and Alternative Medicines, vol. 9, no. 3, pp. 64–72, 2012. View at Google Scholar · View at Scopus
  29. F. Naja, R. A. Fadel, M. Alameddine et al., “Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: a cross-sectional study,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, article 444, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. M. J. Dutta-Bergman, “Primary sources of health information: comparisons in the domain of health attitudes, health cognitions, and health behaviors,” Health Communication, vol. 16, no. 3, pp. 273–288, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Al-Abri and J. E. Mokhbat, “HIV in the MENA region: cultural and political challenges,” International Journal of Infectious Diseases, vol. 44, pp. 64–65, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Alameddine, F. Naja, S. Abdel-Salam, S. Maalouf, and C. Matta, “Stakeholders' perspectives on the regulation and integration of complementary and alternative medicine products in Lebanon: a qualitative study,” BMC Complementary and Alternative Medicine, vol. 11, article no. 71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Naja, M. Alameddine, L. Itani, H. Shoaib, D. Hariri, and S. Talhouk, “The use of complementary and alternative medicine among lebanese adults: results from a national survey,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 682397, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Azaizeh, B. Saad, K. Khalil, and O. Said, “The state of the art of traditional Arab herbal medicine in the Eastern region of the Mediterranean: a review,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 2, pp. 229–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. A. Mahabba, “Anwar Al Mahabba Association,” 2006, http://www.anwaralmahabba.org/.
  36. A. Bowling, “Mode of questionnaire administration can have serious effects on data quality,” Journal of Public Health, vol. 27, no. 3, pp. 281–291, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. I. S. Melki, H. A. Beydoun, M. Khogali, H. Tamim, and K. A. Yunis, “Household crowding index: a correlate of socioeconomic status and inter-pregnancy spacing in an urban setting,” Journal of Epidemiology and Community Health, vol. 58, no. 6, pp. 476–480, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. J. L. Freedman, “What is crowding?” in Crowding and Behavior, WH Freedman, San Francisco, Calif, USA, 1975. View at Google Scholar
  39. F. Naja, D. Mousa, M. Alameddine, H. Shoaib, L. Itani, and Y. Mourad, “Prevalence and correlates of complementary and alternative medicine use among diabetic patients in Beirut, Lebanon: a cross-sectional study,” BMC Complementary and Alternative Medicine, vol. 14, article 185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. S. M. Ching, Z. A. Zakaria, F. Paimin, and M. Jalalian, “Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia,” BMC Complementary and Alternative Medicine, vol. 13, article 148, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. S. S. Hasan, S. I. Ahmed, N. I. Bukhari, and W. C. W. Loon, “Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics,” Complementary Therapies in Clinical Practice, vol. 15, no. 3, pp. 152–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Saad, H. Azaizeh, G. Abu-Hijleh, and O. Said, “Safety of traditional Arab herbal medicine,” Evidence-based Complementary and Alternative Medicine, vol. 3, no. 4, pp. 433–439, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. A. M. Assaf, R. N. Haddadin, N. A. Aldouri et al., “Anti-cancer, anti-inflammatory and anti-microbial activities of plant extracts used against hematological tumors in traditional medicine of Jordan,” Journal of Ethnopharmacology, vol. 145, no. 3, pp. 728–736, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. H. R. El-Seedi, R. Burman, A. Mansour et al., “The traditional medical uses and cytotoxic activities of sixty-one Egyptian plants: discovery of an active cardiac glycoside from Urginea maritima,” Journal of Ethnopharmacology, vol. 145, no. 3, pp. 746–757, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Crouch, R. Elliott, T. Lemmens, and L. Charland, Complementary/Alternative Health Care and HIV/AIDS, 2001.
  46. D. M. Eisenberg, R. B. Davis, S. L. Ettner et al., “Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey,” The Journal of the American Medical Association, vol. 280, no. 18, pp. 1569–1575, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. W. J. Millar, “Use of alternative health care practitioners by Canadians,” Canadian Journal of Public Health, vol. 88, no. 3, pp. 154–158, 1997. View at Google Scholar · View at Scopus
  48. R. Blais, A. Maïga, and A. Aboubacar, “How different are users and non-users of alternative medicine?” Canadian Journal of Public Health, vol. 88, no. 3, pp. 159–162, 1997. View at Google Scholar · View at Scopus
  49. A. H. MacLennan, D. H. Wilson, and A. W. Taylor, “Prevalence and cost of alternative medicine in Australia,” Lancet, vol. 347, no. 9001, pp. 569–573, 1996. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Ramsay, M. Walker, and J. Alexander, Alternative Medicine in Canada: Use and Public Attitudes, Fraser Institute, 1999.
  51. R. Reid, A. Steel, J. Wardle, A. Trubody, and J. Adams, “Complementary medicine use by the Australian population: a critical mixed studies systematic review of utilisation, perceptions and factors associated with use,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, p. 176, 2016. View at Publisher · View at Google Scholar
  52. A. Owen-Smith, F. McCarty, D. Hankerson-Dyson, and R. Diclemente, “Prevalence and predictors of complementary and alternative medicine use in African-Americans with acquired immune deficiency syndrome,” Focus on Alternative and Complementary Therapies, vol. 17, no. 1, pp. 33–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Owen-Smith, R. Diclemente, and G. Wingood, “Complementary and alternative medicine use decreases adherence to HAART in HIV-positive women,” AIDS Care—Psychological and Socio-Medical Aspects of AIDS/HIV, vol. 19, no. 5, pp. 589–593, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. R. A. DeMasi, N. M. Graham, J. M. Tolson et al., “Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome,” Advances in Therapy, vol. 18, no. 4, pp. 163–172, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Nlooto and P. Naidoo, “Traditional, complementary and alternative medicine use by HIV patients a decade after public sector antiretroviral therapy roll out in South Africa: a cross sectional study,” BMC Complementary and Alternative Medicine, vol. 16, article 128, 2016. View at Publisher · View at Google Scholar
  56. M. J. Verhoef, M. S. Rose, M. White, and L. G. Balneaves, “Declining conventional cancer treatment and using complementary and alternative medicine: a problem or a challenge?” Current Oncology, vol. 15, supplement 2, pp. 101–106, 2008. View at Google Scholar
  57. K. I. Block and M. N. Mead, “Immune system effects of echinacea, ginseng, and astragalus: a review,” Integrative Cancer Therapies, vol. 2, no. 3, pp. 247–267, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Escher, J. Desmeules, E. Giostra, and M. Mentha, “Hepatitis associated with kava, a herbal remedy for anxiety,” British Medical Journal, vol. 322, no. 7279, p. 139, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. S. C. Piscitelli, A. H. Burstein, N. Welden, K. D. Gallicano, and J. Falloon, “The effect of garlic supplements on the pharmacokinetics of saquinavir,” Clinical Infectious Diseases, vol. 34, no. 2, pp. 234–238, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Slain, J. R. Amsden, R. A. Khakoo, M. A. Fisher, D. Lalka, and G. R. Hobbs, “Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers,” Pharmacotherapy, vol. 25, no. 2, pp. 165–170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. M. M. R. De Maat, R. M. W. Hoetelmans, R. A. A. Mathôt et al., “Drug interaction between St John's wort and nevirapine,” AIDS, vol. 15, no. 3, pp. 420–421, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. S. C. Piscitelli, A. H. Burstein, D. Chaitt, R. M. Alfaro, and J. Falloon, “Indinavir concentrations and St John's wort,” The Lancet, vol. 355, no. 9203, pp. 547–548, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Stolbach, K. Paziana, H. Heverling, and P. Pham, “A review of the toxicity of HIV medications II: interactions with drugs and complementary and alternative medicine products,” Journal of Medical Toxicology, vol. 11, no. 3, pp. 326–341, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Jou and P. J. Johnson, “Nondisclosure of complementary and alternative medicine use to primary care physicians: findings from the 2012 National Health Interview Survey,” JAMA Internal Medicine, vol. 176, no. 4, pp. 545–546, 2016. View at Publisher · View at Google Scholar
  65. B. Oh, P. Butow, B. Mullan et al., “The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia,” Asia-Pacific Journal of Clinical Oncology, vol. 6, no. 4, pp. 342–349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. M. G. Shedlin, J. K. Anastasi, C. U. Decena, J. O. Rivera, O. Beltran, and K. Smith, “Use of complementary and alternative medicines and supplements by Mexican-origin patients in a U.S.-Mexico border HIV clinic,” Journal of the Association of Nurses in AIDS Care, vol. 24, no. 5, pp. 396–410, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. S. H. Woolf, S. F. Rothemich, R. E. Johnson, and D. W. Marsland, “Selection bias from requiring patients to give consent to examine data for health services research,” Archives of Family Medicine, vol. 9, no. 10, pp. 1111–1118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. L. Nijhawan, M. Janodia, B. Muddukrishna et al., “Informed consent: issues and challenges,” Journal of Advanced Pharmaceutical Technology and Research, vol. 4, no. 3, pp. 134–140, 2013. View at Publisher · View at Google Scholar · View at Scopus